Literature DB >> 24477566

A scoring-system for angiographic findings in nonocclusive mesenteric ischemia (NOMI): correlation with clinical risk factors and its predictive value.

Peter Minko1, Jonas Stroeder, Heinrich V Groesdonk, Stefan Graeber, Matthias Klingele, Arno Buecker, Hans Joachim Schäfers, Marcus Katoh.   

Abstract

PURPOSE: This study was designed to evaluate the clinical value of a standardized angiographic scoring system in patients with nonocclusive mesenteric ischemia (NOMI).
METHODS: Sixty-three consecutive patients (mean age: 73 ± 8 years) with suspect of NOMI after cardiac or major thoracic vessel surgery underwent catheter angiography of the superior mesenteric artery. Images were assessed by two experienced radiologists on consensus basis using a scoring system consisting of five categories, namely vessel morphology, reflux of contrast medium into the aorta, contrasting and distension of the intestine, as well as the time to portal vein filling. These were correlated to previously published risk factors of NOMI and outcome data.
RESULTS: The most significant correlation was found between the vessel morphology and death (p < 0.001) as well as reflux of contrast medium into the aorta and death (p = 0.005). Significant correlation was found between delayed portal vein filling and preoperative statin administration (p = 0.011), previous stroke (p = 0.033), and renal insufficiency (p = 0.043). Reflux of contrast medium correlated significantly with serum lactate >10 mmol/L (p = 0.046). The overall angiographic score correlated with death (p = 0.017) and renal insufficiency (p = 0.02). The ROC-analysis revealed that a score of ≥3.5 allows for identifying patients with increased perioperative mortality with a sensitivity of 85.7 % and a specificity of 49 %. With the use of a simplified score (vessel morphology, reflux of contrast medium into the aorta, and time to portal vein filling), specificity was increased to 71.4 %.
CONCLUSIONS: The applied scoring system allows standardized interpretation of angiographic findings in NOMI patients. Beyond that the score seems to correlate well with risk factors of NOMI and outcome.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24477566     DOI: 10.1007/s00270-014-0844-y

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  6 in total

1.  Nonocclusive mesenteric ischemia secondary to spinal cord injury: an autopsy case.

Authors:  Yu Kakimoto; Yutaka Matsushima; Akio Tsuboi; Yoshihisa Seto; Motoki Osawa
Journal:  Spinal Cord Ser Cases       Date:  2021-05-13

2.  Occurrence and severity of non-occlusive mesenteric ischemia (NOMI) after cardiovascular surgery correlate with preoperatively assessed FGF-23 levels.

Authors:  Jonas Stroeder; Matthias Klingele; Hagen Bomberg; Stefan Wagenpfeil; Arno Buecker; Hans-Joachim Schaefers; Marcus Katoh; Peter Minko
Journal:  PLoS One       Date:  2017-08-08       Impact factor: 3.240

3.  A Retrospective Analysis of Nonocclusive Mesenteric Ischemia in Medical and Surgical ICU Patients: Clinical Data on Demography, Clinical Signs, and Survival.

Authors:  Klaus Stahl; Markus Busch; Sabine K Maschke; Andrea Schneider; Michael P Manns; Jan Fuge; Olaf Wiesner; Bernhard C Meyer; Marius M Hoeper; Jan B Hinrichs; Sascha David
Journal:  J Intensive Care Med       Date:  2019-03-25       Impact factor: 3.510

4.  Non-occlusive mesenteric ischemia (NOMI): evaluation of 2D-perfusion angiography (2D-PA) for early treatment response assessment.

Authors:  Lena S Becker; Klaus Stahl; Timo C Meine; Christian von Falck; Bernhard C Meyer; Cornelia L A Dewald; Nina Rittgerodt; Markus Busch; Sascha David; Frank Wacker; Jan B Hinrichs
Journal:  Abdom Radiol (NY)       Date:  2020-10

5.  Predictors of response to intra-arterial vasodilatory therapy of non-occlusive mesenteric ischemia in patients with severe shock: results from a prospective observational study.

Authors:  Nina Rittgerodt; Thorben Pape; Sascha David; Klaus Stahl; Markus Busch; Lena S Becker; Andrea Schneider; Heiner Wedemeyer; Benjamin Seeliger; Julius Schmidt; Anna Maria Hunkemöller; Jan Fuge; Wolfgang Knitsch; Christine Fegbeutel; Hans-Jörg Gillmann; Bernhard C Meyer; Marius M Hoeper; Jan B Hinrichs
Journal:  Crit Care       Date:  2022-04-04       Impact factor: 9.097

6.  FABP1 and FABP2 as markers of diabetic nephropathy.

Authors:  I-Ting Tsai; Cheng-Ching Wu; Wei-Chin Hung; Thung-Lip Lee; Chin-Feng Hsuan; Ching-Ting Wei; Yung-Chuan Lu; Teng-Hung Yu; Fu-Mei Chung; Yau-Jiunn Lee; Chao-Ping Wang
Journal:  Int J Med Sci       Date:  2020-08-27       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.